If you suffer from seizures, Clonazepam will bring them under control
Clonazepam is one of the highly potent benzodiazepines and it is used to control seizures, or anxiety and panic disorders. For the seizure disorders, Clonazepam is useful either on its own or in combination with other treatments for the petit mal conditions. Clinical studies show that, after treatment, about two-third of all patients remain free of convulsions for a significant period of time. The remaining third have a period of about three months’ remission and then need a further course of treatment. For panic attacks and the associated anxieties including agoraphobia, the clinical evidence shows that Clonazepam achieves a good response over periods of six to nine weeks.
Take the guesswork out of choosing a pharmacy. Order your Clonazepam from the trusted list
How does Clonazepam help?
Researchers have been unable to explain precisely how Clonazepam works. It appears that gamma aminobutyric acid (GABA), which is the main neurotransmitter in the central nervous system, controls the brain’s electrical activity. When someone has a seizure, there is a spike and wave discharge in the brain. If the level of GABA in the brain is enhanced, the spike is suppressed and the amplitude of the discharge is spread. Thus, looking at the clinical evidence, the use of Clonazepam is clearly indicated as an effective means of eliminating seizures or reducing their seriousness in the majority of patients. Similarly, Clonazepam has performed well in the treatment of panic disorders. The fact that we cannot explain how it achieves the effect does not change the reality of that effect.
But there are a number of reasons to approach the use of Clonazepam with caution.
The class of benzodiazepine medications can affect your ability to think and react quickly in emergency situations. This side effect is significantly increased if you mix Clonazepam with alcohol. In general, you should not drive or start to do anything potentially dangerous that requires your full concentration.
In some people, using Clonazepam to control petit mal seizures has stimulated a grand mal attack. If this occurs, you will have to change the dose and add a second anticonvulsant.
There is clear evidence that your body is likely to build up a tolerance for Clonazepam quite quickly. The greater the tolerance, the less effective Clonazepam becomes. This limits Clonazepam to short-term therapies. This need for short-term use is reinforced by the fact that, as one of the benzodiazepines, it can be habit forming. Thus, if Clonazepam is used at high dosage and over an extended period of time, there is a strong likelihood of both physical and psychological dependence. Managing the withdrawal symptoms is more difficult because the underlying condition may have involved anxiety and panic states when confronted by difficult situations.
There is also an emerging series of reports suggesting that there may be an increased risk of a baby being born with birth defects if the mother takes Clonazepam while pregnant. It is still not clear whether this is a genetic predisposition connected with the seizure disorder or that Clonazepam is a contributing factor but caution is advisable.
KLONOPIN was originally developed and sold by Hoffmann-La Roche. In 1997, it was approved as a generic drug (Clonazepam) in the United States. Under both names, it is now widely available in pharmacies and online, being marketed by a number of manufacturers. Because it is one of the more potent benzodiazepines, Clonazepam should not be used for more than 2 to 4 weeks at a time.
